| # | Drug | Count |
|---|---|---|
| 0 | DUPILUMAB | 5 |
| 1 | LEVONORGESTREL | 4 |
| 2 | ETONOGESTREL AND ETHINYL ESTRADIOL | 3 |
| 3 | ETRAVIRINE | 3 |
| 4 | GABAPENTIN | 3 |
| 5 | LEVOTHYROXINE SODIUM | 3 |
| 6 | UPADACITINIB | 3 |
| 7 | ALBUTEROL SULFATE | 2 |
| 8 | ALENDRONATE SODIUM | 2 |
| 9 | CETIRIZINE HYDROCHLORIDE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ETRAVIRINE | 3 | 0.0007 |
| 1 | NELFINAVIR MESYLATE | 1 | 0.0005 |
| 2 | DEFEROXAMINE MESYLATE | 1 | 0.0005 |
| 3 | LAMIVUDINE AND ZIDOVUDINE | 2 | 0.0003 |
| 4 | DARUNAVIR 600 MG | 1 | 0.0002 |
| 5 | ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE | 1 | 0.0002 |
| 6 | ETONOGESTREL AND ETHINYL ESTRADIOL | 3 | 0.0001 |
| 7 | ABACAVIR SULFATE | 1 | 0.0001 |
| 8 | LOPINAVIR AND RITONAVIR | 1 | 0.0001 |
| 9 | ROMOSOZUMAB-AQQG | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 3 | 0.0001 |
| 1 | Protease Inhibitor [EPC] | 3 | 0.0001 |
| 2 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 3 | 0.0001 |
| 3 | Copper-containing Intrauterine Device [EPC] | 2 | 0.0000 |
| 4 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 4 | 0.0000 |
| 5 | Cytochrome P450 3A Inhibitor [EPC] | 2 | 0.0000 |
| 6 | Progestin [EPC] | 7 | 0.0000 |
| 7 | Thiazide-like Diuretic [EPC] | 1 | 0.0000 |
| 8 | Pyrimidine Synthesis Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Insulin [EPC] | 1 | 0.0000 |